inhibition of the bacterial degradation of an active antimicrobial is the basis of clavulanate and sulbactam-potentiated penicillin combinations , and inhibition of degradative pathways in the host is the rationale behind imipenem/cilastatin therapy .
C0038665
sulbactam
C0030842
penicillin